标题
Cisplatin for cancer therapy and overcoming chemoresistance
作者
关键词
-
出版物
Heliyon
Volume 8, Issue 9, Pages e10608
出版商
Elsevier BV
发表日期
2022-09-14
DOI
10.1016/j.heliyon.2022.e10608
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
- (2022) Chen Zhang et al. Molecular Cancer
- A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations—Does One Model Type Fit All?
- (2022) Priyanka Gupta et al. Cancers
- EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
- (2021) Shunsuke Okamura et al. BMC CANCER
- FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway
- (2021) Ya-Kun Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
- (2021) Di Maria Jiang et al. Nature Reviews Urology
- Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
- (2021) Shuai Peng et al. Oncology Letters
- Electronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells
- (2021) Jimmy Manyanga et al. Scientific Reports
- FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
- (2021) Shanyang He et al. Oncogenesis
- TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner
- (2021) Jie Jiang et al. Frontiers in Oncology
- Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation
- (2021) Norfatin Izzatie Mohamad Saimi et al. Pharmaceutics
- Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway
- (2021) Xiao-Zhong Liao et al. Frontiers in Cell and Developmental Biology
- Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models
- (2021) Maofan Zhang et al. Acta Biomaterialia
- Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
- (2021) Ru-pin Alicia Chi et al. BMC CANCER
- Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
- (2021) Jing Guo et al. BMC CANCER
- Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study
- (2021) Berbel L. M. Ykema et al. BMC GASTROENTEROLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts
- (2021) Barbora Peltanova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
- (2021) Mariano Provencio et al. LUNG CANCER
- Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors
- (2021) João Lobo et al. Molecular Oncology
- Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines
- (2021) Nazilah Abdul Satar et al. MOLECULES
- Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis
- (2021) Yinan Wang et al. NANO LETTERS
- MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy
- (2021) Yalda Baghay Esfandyari et al. Reproductive Sciences
- Mechanism and reversal of drug-induced nephrotoxicity on a chip
- (2021) Aaron Cohen et al. Science Translational Medicine
- The miR‑136‑5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells
- (2021) Bo Yang et al. Experimental and Therapeutic Medicine
- Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells
- (2021) Hnin Ei Ei Khine et al. Scientific Reports
- LncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress
- (2021) Xiaofang Zhou et al. Molecular Therapy-Nucleic Acids
- Vestibular Thresholds: A Review of Advances and Challenges in Clinical Applications
- (2021) Megan J. Kobel et al. Frontiers in Neurology
- Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
- (2021) Guiyang Jiang et al. Cancers
- Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways
- (2021) Cinzia Caggiano et al. Cancers
- The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
- (2021) Rina Masadah et al. Cancers
- Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis
- (2021) Guangyue Luo et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis
- (2021) Yangyang Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel
- (2021) Baohua Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
- (2021) Julia C. F. Quintanilha et al. BMC CANCER
- Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis
- (2021) Shanshan He et al. CELLULAR SIGNALLING
- Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways
- (2021) Ana Morelli et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
- (2021) Yuan Cheng et al. Molecular Cancer
- A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
- (2021) Ruijie Zhang et al. PLoS One
- Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
- (2021) Suhail Razak et al. Scientific Reports
- Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy
- (2021) Najiba Chargi et al. Journal of Clinical Medicine
- Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
- (2021) Kristen Renee McSweeney et al. Cancers
- Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells
- (2021) KAZUKI OKUBO et al. ANTICANCER RESEARCH
- Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells
- (2021) Zhigang Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined use of cisplatin plus natural killer cells overcomes immunoresistance of cisplatin resistant ovarian cancer
- (2021) Seung Hee Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer
- (2021) Jing Zhao et al. BIOCHEMICAL PHARMACOLOGY
- Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway
- (2021) Jia-Mei Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
- (2021) Katarina Kalavska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
- (2021) Marinela Bostan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy
- (2021) Guiying Jiang et al. International Journal of Nanomedicine
- Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial
- (2021) Eman Ghonaim et al. MEDICAL ONCOLOGY
- MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer
- (2021) Adil Ali Sayyed et al. MOLECULAR PHARMACEUTICS
- miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1
- (2021) Kuan-bing Chen et al. Cell Death & Disease
- Combination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells
- (2021) Jianwen Gao et al. Experimental and Therapeutic Medicine
- A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer
- (2021) Nicholas Brian Shannon et al. Scientific Reports
- Metronomic Therapy in Oral Squamous Cell Carcinoma
- (2021) Nai-Wen Su et al. Journal of Clinical Medicine
- Regression Modeling of the Antioxidant-to-Nephroprotective Relation Shows the Pivotal Role of Oxidative Stress in Cisplatin Nephrotoxicity
- (2021) Alfredo G. Casanova et al. Antioxidants
- Innovative therapies to tackle platinum-resistant ovarian cancer
- (2021) Amanda B. Keener NATURE
- Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study
- (2021) Akira Ohkoshi et al. ORAL ONCOLOGY
- Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
- (2020) Marta Mariniello et al. Cancers
- Possible Protective Effects of Curcumin via Modulating of Androgen Receptor (AR) and Oct2 Gene Alterations in Cisplatin‐Induced Testicular Toxicity in Rat
- (2020) Amin Abdollahzade Fard et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway
- (2020) Minghe Lv et al. CELL BIOLOGY AND TOXICOLOGY
- Ring finger protein 38 induces the drug resistance of cisplatin in non‐small cell lung cancer
- (2020) Chao Wu et al. CELL BIOLOGY INTERNATIONAL
- Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells
- (2020) Yunxia Li et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin
- (2020) Thana Patimarattananan et al. SUPPORTIVE CARE IN CANCER
- Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)
- (2020) Costantine Albany et al. SUPPORTIVE CARE IN CANCER
- miR‑140‑3p enhances cisplatin sensitivity and attenuates stem cell‑like properties through repressing Wnt/β‑catenin signaling in lung adenocarcinoma cells
- (2020) Shuoming Wu et al. Experimental and Therapeutic Medicine
- Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
- (2020) Yuan Hong et al. Drug Design Development and Therapy
- Chemoresistance in Ovarian Cancer: Prospects for New Drugs
- (2020) Shivani Tendulkar et al. Anti-Cancer Agents in Medicinal Chemistry
- Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
- (2020) Yun-Gyoo Lee et al. BMC CANCER
- Oncolytic HSV therapy modulates vesicular trafficking inducing cisplatin sensitivity and anti-tumor immunity
- (2020) Balveen Kaur et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
- (2020) Christian Pfister et al. EUROPEAN UROLOGY
- Synergistic effects of combined treatment with ultrasound‐mediated cisplatin‐loaded microbubbles and atorvastatin on head and neck cancer
- (2020) Ai‐Ho Liao et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
- (2020) Maria Gebre-Medhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy
- (2020) Lars C. Steggink et al. PHARMACOGENOMICS JOURNAL
- Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
- (2020) Jian-Shu Lou et al. PHYTOMEDICINE
- ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2α mediated glycolysis
- (2020) Hao Yu et al. Molecular Therapy-Nucleic Acids
- m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells
- (2020) Liang Hao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Concomitant weekly cisplatin-based chemoradiotherapy in head and neck cancer: the value of a second measured glomerular filtration rate during treatment
- (2020) Lily Akmar et al. BRITISH JOURNAL OF RADIOLOGY
- PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback
- (2020) Luyan Shen et al. EXPERIMENTAL CELL RESEARCH
- Differential Effects of Clinically Relevant N- versus C-Terminal Truncating CDKN1A Mutations on Cisplatin Sensitivity in Bladder Cancer
- (2020) Rahmat K. Sikder et al. MOLECULAR CANCER RESEARCH
- Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity
- (2020) Mariana Concentino Brum et al. ONCOLOGY REPORTS
- Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment
- (2020) Brian C. Deutsch et al. JAMA Otolaryngology-Head & Neck Surgery
- Oral metronomic therapy in head and neck cancer
- (2020) Raja Pramanik et al. Lancet Global Health
- p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells
- (2020) Shomereeta Roy et al. ARCHIVES OF ORAL BIOLOGY
- Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile
- (2020) Cinzia Federico et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tumor endothelial cells as a potential target of metronomic chemotherapy
- (2019) Ji Yoon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Investigation of Astaxanthin Effect on Cisplatin Ototoxicity in Rats by Using Otoacoustic Emission, Total Antioxidant Capacity, and Histopathological Methods
- (2019) M. Emrah Kınal et al. ENT-EAR NOSE & THROAT JOURNAL
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
- (2019) Shang-Hung Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platinum exposure and cause‐specific mortality among patients with testicular cancer
- (2019) Harmke J. Groot et al. CANCER
- Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity
- (2019) Alfredo G. Casanova et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
- (2019) I. Zapata et al. BMC CANCER
- Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
- (2019) Cecilie Bucher-Johannessen et al. Clinical Epigenetics
- Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
- (2018) Qiling Chen et al. CHEMICAL COMMUNICATIONS
- Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies
- (2018) Faaiza Shahid et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na+/K+-ATPase
- (2018) Jaroslava Šeflová et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
- (2018) Zulfan Zazuli et al. Frontiers in Pharmacology
- Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
- (2018) Xiang Ling et al. ACS Nano
- 1113PThe retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100 mg/m2 to 80 mg/m2 for head and neck cancer (HNC) patients
- (2018) T Oguri et al. ANNALS OF ONCOLOGY
- Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
- (2018) Matthew R. Trendowski et al. CLINICAL CANCER RESEARCH
- Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
- (2018) Shannon Grabosch et al. ONCOGENE
- Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
- (2018) Chao-Yue Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration
- (2017) Yoshitaka Saito et al. LIFE SCIENCES
- Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
- (2017) Navin Sarin et al. PLoS One
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Dr Barnett Rosenberg – a Personal Perspective
- (2016) James D. Hoeschele DALTON TRANSACTIONS
- Spezifische Typen des Harnblasenkarzinoms
- (2016) S. Bertz et al. PATHOLOGE
- Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis
- (2016) Yeter Topcu-Tarladacalisir et al. RENAL FAILURE
- Molecular mechanisms of cisplatin resistance in cervical cancer
- (2016) Xueqiong Zhu et al. Drug Design Development and Therapy
- C-phycocyanin prevents cisplatin-induced mitochondrial dysfunction and oxidative stress
- (2015) Berenice Fernández-Rojas et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
- (2014) S. V. Hato et al. CLINICAL CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Testicular Cancer: A Reflection on 50 Years of Discovery
- (2014) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- 100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs
- (2014) Nicolas P. E. Barry et al. PURE AND APPLIED CHEMISTRY
- Synthetic Methods for the Preparation of Platinum Anticancer Complexes
- (2013) Justin J. Wilson et al. CHEMICAL REVIEWS
- Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials
- (2013) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Mechanistic studies on the reactions of platinum(ii) complexes with nitrogen- and sulfur-donor biomolecules
- (2012) Živadin D. Bugarčić et al. DALTON TRANSACTIONS
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Pt(IV) complexes as prodrugs for cisplatin
- (2011) Yi Shi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Michele Peyrone (1813-1883), Discoverer of Cisplatin
- (2010) George B. Kauffman et al.
- Cisplatin Overdose
- (2009) Roger Y. Tsang et al. DRUG SAFETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now